Patryk Firmanty

Postgraduate School of Molecular Medicine

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies”.

Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies

Frontiers in Immunology(2026)10.3389/fimmu.2026.1749965

N/A

0.330DataRank · unranked

8 citations

Patryk Firmanty, Monika Chomczyk, Vakul Mohanty, Wenxue Ma, Natalia Baran +1 more

Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1409210

N/A

0DataRank · unranked

9 citations

Luca Gazzola, Shubhankar Dash, Patryk Firmanty, Binsah George, Vakul Mohanty +3 more

Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia

Current Pharmacology Reports(2024)10.1007/s40495-024-00378-8

N/A

0DataRank · unranked

3 citations

Monika Chomczyk, Shubhankar Dash, Marina Konopleva, Natalia Baran, Patryk Firmanty